Welcome to LookChem.com Sign In|Join Free

CAS

  • or

139366-35-1

Post Buying Request

139366-35-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

139366-35-1 Usage

General Description

8-Bromo-5-nitroquinoline is a chemical compound that belongs to the class of organic compounds known as nitroquinolines and derivatives. These are compounds containing a quinoline moiety which bears a nitro group. It is characterized by two key functional groups, bromine (Br) attached at position 8 of the quinoline ring and a nitro group (-NO2) at position 5. 8-Bromo-5-nitroquinoline appears as a crystalline solid and is possibly useful for organic synthesis in scientific research. However, specifics about its characteristics, uses, or safety measures can vary and individuals should refer to its product information sheet or other reputable resources for detailed information.

Check Digit Verification of cas no

The CAS Registry Mumber 139366-35-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,9,3,6 and 6 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 139366-35:
(8*1)+(7*3)+(6*9)+(5*3)+(4*6)+(3*6)+(2*3)+(1*5)=151
151 % 10 = 1
So 139366-35-1 is a valid CAS Registry Number.

139366-35-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 8-BROMO-5-NITROQUINOLINE

1.2 Other means of identification

Product number -
Other names 8-Brom-5-nitro-chinolin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:139366-35-1 SDS

139366-35-1Relevant articles and documents

Induction of Axial Chirality in 8-Arylquinolines through Halogenation Reactions Using Bifunctional Organocatalysts

Miyaji, Ryota,Asano, Keisuke,Matsubara, Seijiro

supporting information, p. 9996 - 10000 (2017/08/01)

The enantioselective syntheses of axially chiral heterobiaryls were accomplished through the aromatic electrophilic halogenation of 3-(quinolin-8-yl)phenols with bifunctional organocatalysts that control the molecular conformations during successive halogenations. Axially chiral quinoline derivatives, which have rarely been synthesized in an enantioselective catalytic manner, were afforded in moderate-to-good enantioselectivities through bromination, and an analogous protocol also enabled enantioselective iodination. In addition, this catalytic reaction, which allows enantioselective control through the use of mono-ortho-substituted substrates, allowed the asymmetric synthesis of 8-arylquinoline derivatives bearing two different halogen groups in high enantioselectivities.

Synthesis of 8-heteroaryl nitroxoline analogues via one-pot sequential Pd-catalyzed coupling reactions

Brodnik, Helena,Po?gan, Franc,?tefane, Bogdan

, p. 1969 - 1981 (2016/02/18)

A series of 8-heteroaryl substituted quinolines were prepared, either by direct C-H arylation of five-membered heteroarenes, or Pd-catalyzed coupling of organoboron reagents with bromoquinolines. The use of (benzo)thiophenyl or (benzo)furanyl boron coupling partners allowed further C-H functionalization on the five-membered heteroaryl ring with aryl bromides in one flask to access a variety of polyconjugated molecular architectures. The developed methodology represents a simple approach towards 8-arylated analogues of the biologically interesting nitroxoline core.

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

-

, (2008/06/13)

Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 139366-35-1